The older generation is well aware of the action.French antibacterial drug produced in large quantities on the pharmaceutical market of our country. We are talking about Bioparox, an antibiotic in the form of a spray, which doctors have been prescribing for over forty years for bacterial infections of the respiratory tract and inflammation of the paranasal sinuses. The remedy also helped with acute inflammation, and with a chronically advanced case, and relieved the symptoms of the day after three. However, since the spring of last (2016) year, the medicament has disappeared from the pharmacies, they have stopped prescribing it. And representatives of the French pharmaceutical company "Laboratory Servier" made an official statement on the withdrawal of the aerosol from production.
In this article we will see why "Bioparox" was banned in Russia.
This drug has a depressant effect onbacteria and fungi of various kinds. At one time it was a very popular drug with a pronounced anti-inflammatory effect, released in pharmacies without a prescription. This medicine was prescribed for diseases of the upper respiratory tract with the addition of infections, for example:
But why "Bioparoks" banned in Russia? Let's figure it out.
The main active ingredient of this drug ispolypeptide antibiotic fusafungin, which has a good anti-inflammatory and bacteriostatic effect. This substance was isolated from mold fungus that infects cereals. At one time in the 60s of the last century, the discovery of fusafungin was considered practically a revolution in medicine. The basis of the mechanism of action of this drug is the suspension of the vital activity of microorganisms sensitive to it. It is still unclear for what reason Bioparox was banned in Russia. We understand further.
The drug is active against most species.microorganisms that cause diseases of the upper respiratory tract: staphylococcus, streptococcus, anaerobic bacteria (for the life support of which air is not needed), mycoplasmas, yeast-like fungi of the genus Candida. An important advantage of the drug was that it was not addictive to the microorganisms causing the infection, and it could be used in the next respiratory illness. In the microflora that caused the infection, there was no resistance to this substance. Fusafungin has a depressant effect on the synthesis of elements that cause the inflammatory process, thereby preventing the development of acute inflammation sites. Many wonder why Bioparox was banned in Russia. Analogs should be no less effective.
Accordingly, while reducing the level of inflammationswelling of the mucous membranes of the respiratory organs subsided. In general, the effect of this drug allowed to significantly reduce the frequency of prescription of antibiotics. Even with a complicated sore throat, the duration of medication was reduced, and recovery was faster. The active ingredient "Bioparox" did not penetrate into the blood, and concentrated mainly on the mucous. Three hours after the procedure, the substance was removed from the respiratory tract. The drug was well tolerated by most patients, with rare exceptions. Moreover, no modern medicine can give such a fine dispersion. So why "Bioparox" banned in Russia?
Like any drug, this spray had a number of limitations in the application and its own nuances, sometimes its reception was complicated by side effects. These could be:
This will be the answer to the question of why Bioparox was banned in Russia. How to replace it, tell below.
In various sources, two versions were discussed.removal of "Bioparox" from production. According to the first, the drug was banned precisely because of complications and deaths. The facts of death entailed mass checks in all states where this drug was sold. It should be noted that complications can arise from any medicinal product if the patient neglects the recommendations and warnings of the manufacturer. The second version says that the pharmaceutical company "Tantum Verde" has initiated an additional study of this drug to the effect that the main active ingredient is a danger to patients. The result of the research was the conclusion of experts, which said about the danger of fusafungin, which was the source of all side effects, even deaths.
That is why Bioparox was banned in Russia. Reviews confirm this.
The drug was thoroughly tested, and the commission came to some disappointing conclusions.
Over time, the therapeutic effect of thisthe drug is significantly reduced, because the use of fusafungin causes the disease-causing bacteria not only to mutate, but also to acquire resistance to other antibacterial agents.
During the laboratory tests was formedtwo groups, in one of them Bioparox was assigned, in the second a dummy was used. According to the results of the research, it turned out that patients from both groups recovered almost equally, recovery in the placebo group was slightly delayed. As a result of these studies, Bioparox was banned in Russia. There were a lot of reviews about this.
Complications such as bronchospasm can cause death.
The risk of spasms was discussed ininstructions, but not everyone knew that an allergic reaction in this case was life-threatening, and sometimes it could just be fatal. Doctors in Russia knew about this danger, therefore, when prescribing the drug, they were always interested in the presence of allergic reactions in the patient. But in this case, scientists have found that a spasm can occur in a patient who does not suffer from allergies, just the effect of fusafungin.
The benefits of this medicationincommensurable less than the possible complications (cramps, anaphylactic shock). That is, the existing risk of death from the use of "Bioparox" in this case is not justified by the relative ease of occurrence of diseases of the upper respiratory tract. Now Bioparox is banned in Russia. The reasons for this are very serious.
Spray, like all drugs, based onFusafungin, discontinued. Moreover, the remaining pharmaceutical batches were removed from the pharmacy chains and they warned doctors and patients that it poses a danger to life. Although, in the opinion of many patients taking this drug, it had an excellent therapeutic effect and in some cases there is simply nothing to replace it, since there are no analogues. Nevertheless, Bioparox was banned in Russia.
As we have said, Bioparox does not haveone hundred percent accurate analogs, but lately the pharmaceutical industry has launched the release of even more effective antibacterial drugs that do not cause respiratory cramps. The list of drugs that can be replaced by the above indicated spray is quite large, you can choose according to your wishes. First of all, this is a group of drugs brand "Tantum Verde" - antiseptics of various kinds ("Miramistin", "Hexoral", "Octenisept").
It may also be drugs in the form ofaerosols or eucalyptus-menthol tablets, as well as drugs based on iodine - all of these drugs have exactly the same effect in sore throat as Bioparox.
In addition, the doctor may prescribe the intake of antibacterial drugs.
As you can see, there are more analogues thanenough, and many of them are much more effective and even outperform the drug with fusafungin due to the complex composition and the cumulative effect on all the symptoms of diseases. In addition to adult patients, this medication was prescribed for children over 12 years of age.
And many parents, regardless of the instructions,used the drug for children at a younger age, which naturally created the risk of complications. Therefore, a ban on the production of this spray from the point of view of the safety of our children is quite an adequate decision of medical specialists. They should not be neglected. It is better to purchase an effective analogue in a pharmacy and use it without fear of serious complications. Now you know the answer to the question of why Bioparox was banned in Russia.
